Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

769
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
769
Censoring Survival Data01:09

Censoring Survival Data

688
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
688
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

996
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
996
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

498
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
498
Life Tables01:22

Life Tables

670
A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
670
Survival Curves01:18

Survival Curves

936
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
936

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EMERGE Mothers and Kids: a longitudinal cohort study of mothers and children enrolled in the randomized placebo-controlled trial of metformin in women with GDM (EMERGE): study protocol.

Trials·2026
Same author

The role of male foetal sex on maternal and neonatal outcomes in pregnancies complicated by gestational diabetes-secondary analysis of a randomised placebo controlled clinical trial of metformin in gestational diabetes (EMERGE).

BMC medicine·2026
Same author

Navigating Complexities In Randomized Trials: Insights From The EMERGE Trial Amidst Pandemic And Cybersecurity Threat.

HRB open research·2026
Same author

Prediction of time to insulin initiation in gestational diabetes mellitus: a secondary analysis of the EMERGE trial.

Diabetes research and clinical practice·2025
Same author

Antidepressant efficacy and safety of scopolamine in individuals with bipolar disorder (SCOPE-BD): A randomized double-blind placebo-controlled trial.

Journal of affective disorders·2025
Same author

Antiphospholipid antibodies and subclinical interstitial lung disease in the MESA cohort.

Respiratory research·2025

Related Experiment Video

Updated: Apr 18, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.1K

Summarising censored survival data using the mean residual life function.

Alberto Alvarez-Iglesias1, John Newell, Carl Scarrott

  • 1HRB Clinical Research Facility, National University of Ireland Galway, Galway, Ireland.

Statistics in Medicine
|January 29, 2015
PubMed
Summary

This study introduces a new semi-parametric method to estimate mean residual life, effectively handling censored survival data. The approach improves time-based treatment effect summaries by modeling the upper tail of survival distributions.

Keywords:
extreme value theorygeneralised Pareto distributionmean residual lifesurvival analysis

More Related Videos

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

9.0K
Measurement of Lifespan in Drosophila melanogaster
10:00

Measurement of Lifespan in Drosophila melanogaster

Published on: January 7, 2013

35.9K

Related Experiment Videos

Last Updated: Apr 18, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.1K
Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions
05:18

Measurement of Survival Time in Brachionus Rotifers: Synchronization of Maternal Conditions

Published on: July 22, 2016

9.0K
Measurement of Lifespan in Drosophila melanogaster
10:00

Measurement of Lifespan in Drosophila melanogaster

Published on: January 7, 2013

35.9K

Area of Science:

  • Biostatistics
  • Survival Analysis
  • Statistical Modeling

Background:

  • Mean residual life (MRL) offers intuitive time-based summaries of treatment or risk factor effects.
  • Estimating MRL is challenging due to right-censored survival data, where patient follow-up is incomplete.
  • Existing methods for MRL estimation with censoring have limitations in accurately capturing long-term survival patterns.

Purpose of the Study:

  • To develop a novel semi-parametric method for estimating mean residual life in the presence of right-censored data.
  • To improve the accuracy of time-based survival effect summaries by addressing limitations in modeling the upper tail of survival distributions.
  • To integrate non-parametric techniques with extreme value theory for robust MRL estimation.

Main Methods:

  • A novel semi-parametric approach combining established non-parametric methods with an extreme value tail model.
  • Utilizing limited sample information from the tail of the survival distribution before study termination.
  • Application and validation using both simulated datasets and real-world clinical data.

Main Results:

  • The proposed method effectively estimates mean residual life even with significant right censoring.
  • The integration of extreme value tail modeling enhances the accuracy of upper tail behavior estimation.
  • Demonstrated performance through simulations and real-life examples, showing improved estimation compared to traditional methods.

Conclusions:

  • The novel semi-parametric method provides a more reliable estimation of mean residual life for censored survival data.
  • This approach offers a valuable tool for interpreting treatment effects and risk factors in time units.
  • The method enhances the understanding of long-term survival outcomes in clinical research.